Bone Cancer Drug Suits Try To Break Novartis

Law360, New York (June 26, 2007, 12:00 AM EDT) -- Drugs aimed at treating bone cancer and osteoporosis have suddenly become big business for plaintiffs attorneys, who continue to file suits against health care giants like Novartis Pharmaceutical Corp. alleging the medications have led to the painful deterioration of the jawbone.

Novartis is one of a slew of big-name drug makers that has found itself the target of a multidistrict product liability case in recent years, with a class of drugs known as bisphosphonates at the center of the gathering storm.

Over the past few years,...
To view the full article, register now.